Easter Bush Pathology, The Royal (Dick) School of Veterinary Studies and The Roslin Institute, University of Edinburgh, Roslin, UK; Diagnostic Laboratory, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Companion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Vet J. 2021 Aug;274:105715. doi: 10.1016/j.tvjl.2021.105715. Epub 2021 Jul 9.
The aim of this study was to serially evaluate the serum concentrations of total thyroxine (tT4), free thyroxine (fT4) and thyroid-stimulating hormone (TSH) in dogs with canine parvoviral enteritis (CPVE) during a 5-day hospitalisation period and assess the association of these hormone concentrations with the outcome and the development of systemic inflammatory response syndrome (SIRS). Dogs with confirmed CPVE that were hospitalised for at least 5 days were included. The thyroid hormones concentrations were measured on days 1, 3 and 5 of hospitalisation. Twenty-eight dogs were included. All (28/28, 100%), 19/28 (69.7%) and 23/28 (82.1%) dogs had a low serum tT4, fT4 and TSH concentration, respectively, on at least 1 day during the hospitalisation period. Overall, 11/28 (39.3%) dogs were diagnosed with SIRS on at least 1 day. In survivors, serum tT4 concentration was significantly higher on day 5 (median, range: 11.8 nmol/L, <6.4-32.2 nmol/L) compared to those on days 1 (<6.4 nmol/L, <6.4-20.1 nmol/L; P = 0.010) or 3 (7.6 nmol/L, <6.4-25.2 nmol/L; P = 0.019). Survivors had a significantly higher tT4 concentration (median, range: 11.8 nmol/L, <6.4-32.2 nmol/L) on day 5 compared to non-survivors (<6.4 nmol/L, <6.4-7.2 nmol/L; P = 0.002). Regardless of the day of hospitalisation, dogs with SIRS had significantly lower tT4 (<6.4 nmol/L, <6.4-16.3 nmol/L) compared to dogs without SIRS (8.6 nmol/L, <6.4-32.2 nmol/L; P = 0.006). A significant difference was also found in fT4 between dogs with SIRS (<3.9 pmol/L, <3.9-16.2 pmol/L) and dogs without SIRS (15.1 pmol/L, <3.9-59.2; pmol/L; P < 0.001). Non-thyroidal illness syndrome was frequently observed in dogs with CPVE, and a negative association between tT4 and fT4 concentrations and SIRS was noted. Serial measurements of tT4 concentrations appeared to have prognostic value.
本研究旨在连续评估犬细小病毒性肠炎(CPVE)住院期间犬的血清总甲状腺素(tT4)、游离甲状腺素(fT4)和促甲状腺激素(TSH)浓度,并评估这些激素浓度与结局和全身炎症反应综合征(SIRS)的发展之间的相关性。纳入至少住院 5 天的确诊 CPVE 犬。在住院第 1、3 和 5 天测量甲状腺激素浓度。共纳入 28 只犬。所有(28/28,100%)、19/28(69.7%)和 23/28(82.1%)犬在住院期间至少有 1 天血清 tT4、fT4 和 TSH 浓度降低。总体而言,28 只犬中有 11/28(39.3%)至少有 1 天被诊断为 SIRS。存活者第 5 天血清 tT4 浓度显著高于第 1 天(中位数,范围:11.8 nmol/L,<6.4-32.2 nmol/L)和第 3 天(7.6 nmol/L,<6.4-25.2 nmol/L;P=0.019)。存活者第 5 天 tT4 浓度(中位数,范围:11.8 nmol/L,<6.4-32.2 nmol/L)显著高于非存活者(<6.4 nmol/L,<6.4-7.2 nmol/L;P=0.002)。无论住院天数如何,患有 SIRS 的犬的 tT4 显著低于无 SIRS 的犬(<6.4 nmol/L,<6.4-16.3 nmol/L)(8.6 nmol/L,<6.4-32.2 nmol/L;P=0.006)。患有 SIRS 的犬的 fT4 与无 SIRS 的犬的 fT4 也存在显著差异(<3.9 pmol/L,<3.9-16.2 pmol/L)和无 SIRS 的犬(15.1 pmol/L,<3.9-59.2;pmol/L;P<0.001)。CPVE 犬常出现非甲状腺疾病综合征,tT4 和 fT4 浓度与 SIRS 呈负相关。tT4 浓度的连续测量似乎具有预后价值。